Subcutaneous immunoglobulin infusion to treat infants and toddlers with antibody deficiencies.
Meth
Marc J
MJ
Rosenthal
David W
DW
Bonagura
Vincent R
VR
D000911:Antibodies, Monoclonal / Q000009:adverse effects; D058846:Antibodies, Monoclonal, Murine-Derived; D002675:Child, Preschool; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000097:blood / Q000172:deficiency / Q000627:therapeutic use*; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007153:Immunologic Deficiency Syndromes / Q000097:blood / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology; D007223:Infant; D007239:Infections; D055104:Infusions, Subcutaneous; D008231:Lymphopenia; D008297:Male; D000069283:Rituximab; D053632:X-Linked Combined Immunodeficiency Diseases / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous; D000069283:Rituximab